New Enterprise Associates 15 L.P. 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-08 7:34 pm Sale |
2024-10-04 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
New Enterprise Associates 15 L.P. | 0 0.000% |
-478,549 (Position Closed) |
Filing |
| 2024-05-08 4:33 pm Unchanged |
2024-05-07 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
New Enterprise Associates 15 L.P. | 478,549 14.300% |
0 (Unchanged) |
Filing |
| 2021-04-23 08:46 am Purchase |
2021-04-13 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
New Enterprise Associates 15 L.P. | 478,549 19.800% |
478,549 (New Position) |
Filing |